Myeloid Sarcoma
📧 Sign up to get email alerts when something new happens for Myeloid Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML [Phase 1]
Phase 1 trial to assess the safety and tolerability of Ziftomenib in combination with Venetoclax/Azacitidine, Venetoclax alone, or 7+3 with …
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation [Phase 2]
This clinical trial update describes a Phase 2 study evaluating TCRγδ T cells and memory T cells with selective use of blinatumomab as part …
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma [Phase 2]
Phase 2 clinical trial evaluating the VAM regimen in secondary acute myeloid leukemia, AML with extramedullary involvement, and myeloid sarc…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
This clinical trial is testing an intensive conditioning regimen consisting of Thiotepa, Busulfan, Fludarabine, and Cytarabine followed by a…